Furthermore, a negative association was found between high levels of LFA-1 and poorer survival in patients with solid cancers, including colorectal adenocarcinoma, uveal melanoma, lower grade glioma, or renal cell carcinoma (Supplemental Figure 8, D–G). This evidence concerns the gene ITGB2 and colorectal adenocarcinoma.